BIOMEDICA NT-proBNP and NT-proANP ELISA kits for preclinical toxicology testing
Cardiac toxicity is a leading cause of preclinical safety failures in drug development. The cardiac markers NT-proANP and NT-proBNP have proven to be useful in preclinical toxicology testing.
The BIOMEDICA NT-proBNP and NT-proANP ELISA kits are robust assays to quantify these cardiac hormones in rat samples. The NT-proANP ELISA kit is widely published for use in rat samples and has been independently validated for cardiovascular safety studies in rats.
Features of these quantitative ELISAs for translational research and drug discovery include: only 10 µL/well required, serum or plasma; kit control included; sample values provided; widely cited; suitable for use in human and non-human samples (high cross-reactivity between species).
For further information, visit https://www.bmgrp.com/cardiac-safety-biomarker-assays-in-preclinical-toxicology/ or contact United Bioresearch Products, who distributes the full BIOMEDICA range in Australia, at (02) 4575 0309 or info@unitedbioresearch.com.au.
Phone: 02 4575 0309
Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research
Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...
TopoGEN Topoisomerase Assay Kits
TopoGEN provides innovative reagents and kits for topoisomerase research and mechanism-based drug...
Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis
The multiplex panel encompasses a wide selection of proteins essential for studying key...
Learn More
I am interested in BIOMEDICA NT-proBNP and NT-proANP ELISA kits for preclinical toxicology testing.
Complete the form and a supplier representative will be in touch.
